Inspire Medical Q4 revenue $239.7M (+25% YoY); EPS $1.15; guides FY2025 rev $940-955M

Inspire Medical Systems, Inc.

2024-FY EPS reported $1.75 revenue$802,804,000

Q4 revenue $239.7M (+25% YoY); net income $35.2M, diluted EPS $1.15 vs $0.49 prior year.
Full year 2024 revenue $802.8M (+28% YoY); net income $53.5M ($1.75 diluted EPS) vs net loss in 2023.
FY2025 guidance: revenue $940-955M (17-19% growth); diluted EPS $2.10-$2.20.
Added 72 U.S. centers in Q4 (total 1,435); U.S. sales territories now 335; over 90,000 patients treated.
Initiated $75M accelerated share repurchase program; operating cash flow $130.2M for full year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.